NCT02176252View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamic of AZD1722 in Healthy Male and Female Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteer
Interventions
DRUG

AZD1722

DRUG

Placebo

Trial Locations (1)

90630

WCCT Global, Cypress

Sponsors

Lead Sponsor

Ardelyx

Collaborators (1)

AstraZeneca
All Listed Sponsors
lead

Ardelyx

INDUSTRY

collaborator

AstraZeneca

INDUSTRY